SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VARANI, Katia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.388
EU - Europa 9.520
AS - Asia 7.482
SA - Sud America 34
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 17
AF - Africa 8
Totale 48.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.276
CN - Cina 3.610
UA - Ucraina 2.275
DE - Germania 2.080
TR - Turchia 1.756
SG - Singapore 1.713
IT - Italia 1.679
GB - Regno Unito 1.017
SE - Svezia 742
FI - Finlandia 668
PL - Polonia 316
RU - Federazione Russa 217
FR - Francia 145
BE - Belgio 120
ID - Indonesia 114
HK - Hong Kong 109
CA - Canada 108
VN - Vietnam 83
CZ - Repubblica Ceca 59
NL - Olanda 57
LT - Lituania 42
IN - India 21
BR - Brasile 20
ES - Italia 20
IR - Iran 20
CH - Svizzera 19
EU - Europa 18
JP - Giappone 15
AT - Austria 12
AU - Australia 12
RO - Romania 10
IE - Irlanda 9
CL - Cile 8
KR - Corea 6
HU - Ungheria 5
IL - Israele 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
GR - Grecia 4
HR - Croazia 4
MX - Messico 4
MY - Malesia 4
NO - Norvegia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
IQ - Iraq 3
JO - Giordania 3
MA - Marocco 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CO - Colombia 2
DZ - Algeria 2
IM - Isola di Man 2
MD - Moldavia 2
TH - Thailandia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MC - Monaco 1
ME - Montenegro 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
Totale 48.470
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.958
Fairfield 3.394
Jacksonville 2.602
Chandler 2.498
Houston 2.382
Ann Arbor 2.135
Ashburn 1.770
Santa Clara 1.697
Wilmington 1.418
Singapore 1.362
Seattle 1.328
Cambridge 1.109
Izmir 893
Nanjing 783
Beijing 662
Princeton 585
Boardman 470
Ferrara 454
Milan 312
Warsaw 312
San Diego 302
Shanghai 302
Nanchang 250
Shenyang 232
Los Angeles 210
Dearborn 179
Helsinki 169
Bremen 167
Changsha 148
Hebei 148
New York 146
Tianjin 143
Addison 140
Jiaxing 136
Brussels 118
Jakarta 113
Hong Kong 106
San Mateo 99
London 98
Falls Church 90
Jinan 87
Norwalk 83
Zhengzhou 83
Dong Ket 81
Kunming 77
Munich 72
Mountain View 70
Auburn Hills 59
Orange 58
Toronto 57
Düsseldorf 54
Ningbo 53
Frankfurt am Main 52
Guangzhou 50
Redwood City 49
Philadelphia 47
Washington 43
Des Moines 39
Brno 37
Tappahannock 37
Bologna 35
Taizhou 34
Falkenstein 33
Augusta 32
Indiana 30
Rome 29
Verona 29
Chicago 28
Hangzhou 28
Ottawa 28
Lanzhou 25
Redmond 21
Hefei 19
Haikou 17
Leawood 17
Olomouc 17
Ardabil 16
Ferrara di Monte Baldo 16
Florence 16
Kilburn 16
Zurich 15
San Francisco 13
Changchun 12
Espoo 12
Bari 11
Chiswick 11
Padova 11
Aversa 9
Ipswich 9
Meppel 9
Otura 9
Taiyuan 9
Amsterdam 8
Hounslow 8
Monmouth Junction 8
Naples 8
Nice 8
Cagliari 7
Dublin 7
Edinburgh 7
Totale 35.285
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 342
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 239
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 204
A glance at adenosine receptors: Novel target for antitumor therapy 202
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 201
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 198
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 189
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 174
Pharmacology of Adenosine Receptors: The State of the Art 169
The A3 adenosine receptor: history and perspectives 167
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 166
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 166
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 162
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 161
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 161
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 160
Recettori e trasduzione del segnale 156
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 155
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 153
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 152
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 151
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 149
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 147
Adenosine receptors and human melanoma 146
Pathological overproduction: the bad side of adenosine 146
Adenosine receptor targeting in health and disease 145
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 145
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 144
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 144
Current status of A1 adenosine receptor allosteric enhancers 143
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 143
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 141
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 140
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 139
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 139
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 138
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 138
Recettori e trasduzione del segnale 137
Comparison of Prazosin, Terazosin and Tamsulosin: Functional and Binding Studies in Isolated Prostatic and Vascular Human Tissues. 137
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 137
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 137
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 134
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 134
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 133
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 133
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 132
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 131
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 131
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 131
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 131
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 131
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 131
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 130
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 130
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 130
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 129
Ala scan analogues of HOE 140. Synthesis and biological activities 129
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 129
Binding thermodynamics at A1 and A2A adenosine receptors 128
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 128
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 128
A Consensus Panel Review of Central Nervous System Effects of the Exposure to Low-Intensity Extremely Low-Frequency Magnetic Fields 128
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 127
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 127
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 127
Adenosine signaling contributes to ethanol-induced fatty liver in mice 126
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 126
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 125
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 125
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 125
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 125
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 125
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 124
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 124
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 124
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 123
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 123
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 123
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 123
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 123
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 123
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 123
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 122
New potent and selective human adenosine A3 receptor antagonists. 122
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 121
Biochemical characterization of A1 adenosine receptors: experimental evaluation of their binding and intrinsic activity parameters 121
null 121
Functional tissue engineering in articular cartilage repair: is there a role for electromagnetic biophysical stimulation? 120
Electrophysiological basis for the enhanced cardiac arrhythmogenic effect of isoprenaline in aged spontaneously hypertensive rats 119
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 119
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 119
Conformational Aspects of Human Formyl-peptide Receptor Agonists 119
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 119
Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2receptor agonists 119
Adenosine and lymphocyte regulation 119
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists. 118
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 118
A(2A) adenosine receptors in human peripheral blood cells 118
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 118
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 118
Totale 14.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 222.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.914
Totale 227.671
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.957 0 0 0 0 0 1.027 757 906 636 1.021 463 147
2020/20216.868 600 670 242 788 344 711 276 826 165 951 888 407
2021/20225.145 126 552 340 225 245 210 232 269 193 432 731 1.590
2022/20235.734 592 432 176 795 954 821 269 458 700 46 296 195
2023/20242.851 289 377 142 83 316 343 136 209 57 72 77 750
2024/20254.776 311 354 946 618 1.431 1.116 0 0 0 0 0 0
Totale 49.149